Mark S. Germain is listed as a director on 3 SEC Form D filings by 1 issuer between Feb 2012 and Oct 2014: ChromaDex Corp. (Los Angeles, CA — biotechnology — 2012–2014; $25M reported sold to 45 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Barry Honig (3 shared filings), Frank L. Jaksch (3 shared filings), Glenn L. Halpryn (3 shared filings), Michael Brauser (3 shared filings), Reid Dabney (3 shared filings) and 9 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Mark. Each name links to their own page.
The issuer belongs to the sponsor group Chromadex (2 issuers, $3.1M reported sold, 2010–2022).
What this means A sponsor group is one team that sets up a new company for each deal. Chromadex has 2 companies on file and $3.1M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 8 bankruptcy cases matching the name listed in Key records below.
What this means 8 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 3 public filings for Mark S. Germain and found 5 differences: No amendment in the last 12 months on an offering that may still be open; Same name, different state: "Mark Germain" (L3) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.